--2025/Q1-- / 3.050M--
--2024/Q4-- / 3.733M--
--2024/Q31.142M / 3.000M--
--2024/Q2598.000K / 9.850M--
--2024/Q112.406M / 3.550M--
Apple
AAPL
Oracle
ORCL
Adobe
ADBE
Ecopetrol
EC
D.R. Horton
DHI
US Stock MarketDetailed Quotes
SLN Silence Therapeutics
- 6.330
- -0.180-2.76%
Close Dec 18 16:00 ET
298.87MMarket Cap-3.75P/E (TTM)
6.670High6.280Low614.65KVolume6.580Open6.510Pre Close3.97MTurnover2.40%Turnover RatioLossP/E (Static)47.21MShares27.72052wk High2.51P/B162.16MFloat Cap5.81052wk Low--Dividend TTM25.62MShs Float35.000Historical High--Div YieldTTM5.99%Amplitude4.545Historical Low6.452Avg Price1Lot Size
Silence Therapeutics Key Stats
Silence Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: GBP
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Silence Therapeutics Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data